CAS RN: 501357-90-0
Pyrido[3′,2′:4,5]thieno[3,2-d]pyriMidine-2,4(1H,3H)-dione
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 501357-90-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
501357-90-0 / 8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene-4,6-dione
Standard CAS: 501357-90-0
Multi CAS: No
Basic Information
copy
CAS
501357-90-0 copy
Multi CAS
No copy
Molecular Formula
C9H5N3O2S copy
Molecular Weight
219.220000 copy
Exact Mass
219.010248 copy
InChI
InChI=1S/C9H5N3O2S/c13-7-6-5(11-9(14)12-7)4-2-1-3-10-8(4)15-6/h1-3H,(H2,11,12,13,14) copy
InChIKey
SOWCVDMRPMZWHX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
13 copy
H-bond acceptors
4 copy
H-bond donors
2 copy
Molar refractivity
58.37 copy
TPSA
78.61 copy
LogP / Solubility
WLOGP
0.83 copy
MLOGP
0.73 copy
XLogP3
1.1 copy
Consensus LogP
0.89 copy
Log S (ESOL)
-2.36 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.95 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.77 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.47 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy